BioLineRx (BLRX) Receivables (2010 - 2025)
BioLineRx (BLRX) posted Receivables of $502,000 for the quarter ended Dec 31, 2025, down 90.8% from $5.43 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Receivables (2010 - 2025) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Receivables came in at $866,000, down 84.1% from the prior year.
- Annual Receivables shows a three-year compound annual growth rate of -15.6% (years ended Dec 2022 to Dec 2025).
- In prior years, BioLineRx's Receivables was $5.43 million in the year ended Dec 31, 2024 (+169.2%), $2.02 million in the year ended Dec 31, 2023 (+39.9%) and $1.44 million in the year ended Dec 31, 2022.
- Quarterly Receivables has run from a low of $281,000 in the quarter ended Jun 30, 2025 to a high of $5.43 million in the quarter ended Dec 31, 2024 over five years.
- On a year-over-year basis, Receivables increased in 1 of the last four quarters, with an average decline of 14.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | BioLineRx | 9.10 Mn | -67.42 Mn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 866,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 5.43 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2020 | 895,000.00 |
| Dec 31, 2019 | 2.07 Mn |
| Jun 30, 2011 | 3.83 Mn |
| Dec 31, 2010 | 3.56 Mn |
API Access
BioLineRx Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();